Author: Acteropharma
Regarding the Importance of experience sharing about Lung cancer patients with COVID-19 complications, a multidisciplinary virtual Meeting was held on December 3rd 2020, with the topic of “Lung Cancer & COVID19” with the presence of Dr. Khosravi (Medical Oncologists), Dr. Seifi (Medical Oncologists), Dr. Salimi (Medical Oncologists), Dr. Kiani (Pulmonologist), Dr. Naseri (Radio Oncologist), Dr. Bakhshayesh karam (Radiologist), Dr. Daneshvar (Thoracic Surgeon).
Erlotinib ACTe & Pemetrexed ACTe are two ACTERO’s products, which has a certain position in lung cancer treatment.
Author:
Author:
Author: